跳至主要内容
临床试验/ISRCTN76123473
ISRCTN76123473已完成不适用

Randomised controlled trial of nocturnal insulin glargine versus human insulatard in combination with metformin in patients with type two diabetes currently treated with metformin/insulatard combination therapy

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)0 个研究点目标入组 80 人开始时间: 2003年9月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 80 patients.

排除标准

  • Not provided at time of registration

研究者

发起方
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)

相似试验

已完成
3 期
A placebo-controlled trial of insulin therapy with or without adjuvant metformin in patients with Cystic Fibrosis-Related Diabetes10038686Cystic Fibrosis10018424
NL-OMON38078HagaZiekenhuis25
进行中(未招募)
不适用
A placebo-controlled trial of insulin therapy with or without adjuvant metformin in patients with cystic fibrosis-related diabetes - Insulin therapy and adjuvant metformin in CFRDCystic fibrosis-related diabetesMedDRA version: 9.1Level: HLTClassification code 10012602Term: Diabetes mellitus (incl subtypes)MedDRA version: 9.1Level: LLTClassification code 10011762Term: Cystic fibrosis
EUCTR2009-009875-37-NLStaf Longziekten25
进行中(未招募)
不适用
Prospective influence of bedtime insulin glargine on mobilization and function of endothelial progenitor cells in patients with type 2 diabetes: a partially double-blind, randomized, three-arm unicenter study - Glargine and EPCThe medical disease that will be investigated is type 2, diabetes mellitus. The patients who will be investigated are between 35 and 70 years old and on oral antidiabetic therapy.MedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitus
EUCTR2006-006573-24-DEniversity Hospital of Heidelberg
招募中
不适用
Blood sugar control after bypass operation - insulin vs oral medicatioheart disease, diabetes
SLCTR/2014/024ational Hospital of Sri Lanka330
已完成
不适用
The safety and efficacy of short course intravenous antibiotic therapy for the resolution of acute cellulitis and erysipelas
ACTRN12613001366741Barwon Health80